Another study created Y1 receptor ligand (NPY)-modified bubbles, finding that, compared with modified bubbles without NPY targeting, NPY-modified bubbles group showed a high tumor suppression effect and a prolonged survival time in Y1 receptor-overexpressed breast cancer treatments (Qian et al., 2020). Here, NPY is linked to neoplasm.